Generate a tailored SOP for Dr. Veda Giri. Improve your application with a focused, well-structured draft.
Veda N. Giri, MD, is a medical oncologist with a specialization in clinical cancer genetics at Yale School of Medicine. As the Division Chief of Clinical Cancer Genetics at Yale Cancer Center and Smilow Cancer Hospital, she leads comprehensive cancer genetic evaluations that inform precision medicine, tailored cancer screening, and hereditary cancer risk assessment. Her significant contributions to the field include starting the Men’s Genetic Risk Clinic in 2014, focusing on inherited prostate cancer, and co-chairing the 2017-2019 Philadelphia Prostate Cancer Consensus Conferences. Dr. Giri's research aims to address disparities in access to genetic testing and counseling while exploring the genetic evaluation of cancer risk across various populations. She currently serves on multiple national committees and has been recognized as a Fellow of the American Society of Clinical Oncology (FASCO). Her educational background includes an MD from Sidney Kimmel Medical College and advanced training in molecular cancer genetics. Dr. Giri's passion for integrating genetics into oncology allows her to improve patient outcomes through innovative research and patient care strategies.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.